TrialTrials2016

Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.

Dimitrios Chanouzas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.